World Generic Congress LatAm 2012

The World Generics Congress LatAm is dedicated to challenges and opportunities in generic drug development in Latin America.

The World Generics Congress LatAm covers topics such as:

• Market review for generics in Latin America
• Sustainability of healthcare in Latin America
• Regional regulatory policy
• Government responsibility and role in generic drug development
• Biosimilars in Latin America
• Development trends and target indications

The World Generics Congress LatAm brings together Representatives from: biosimilars developers, generic drug manufacturers, government, CMOs, biotech, pharma and bioequivalence testing services.